Hepatitis B Virus (HBV): Clinical Trials

10 trials for Hepatitis B Virus (HBV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 not yet recruiting, 3 recruiting, 1 unknown. 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 42Not yet recruiting 1, Recruiting 1
Phase 11Completed 1
Phase 21Unknown 1
Phase 31Completed 1

Follow Hepatitis B Virus (HBV): new trials by email Literature Review of Hepatitis B Virus (HBV) trials Research Report on Hepatitis B Virus (HBV)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combating Related Epidemics in HCV
Cepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2 - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV)
Phase 4Not yet recruitingDuke University12802027-01-202026-10-15
Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
Rapid Fingerstick Test, Blood Draw for lab test - HIV Testing, HEPATITIS C (HCV)
RecruitingWest Virginia University2002026-01-212026-08-13
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Entecavir, HBIG, EVLP UV Light Treatment - Hepatitis B Virus (HBV), Lung Transplant Recipient
Phase 4RecruitingUniversity Health Network, Toronto202025-09-242025-11-17
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
Community screening for hepatitis B, C and delta in the Mongolian population living in France - HEPATITIS C (HCV), Hepatitis B Virus (HBV)
Not applicableNot yet recruitingHospices Civils de Lyon20002025-09-012025-06-26
The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms
Hepatitis B Virus (HBV)
Not yet recruitingNottingham University Hospitals NHS Trust302025-08-012025-07-16
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Peg IFN-α-2b - Hepatitis B, Chronic (CHB), Hepatitis B
RecruitingFirst Affiliated Hospital Xi'an Jiaotong University15002025-01-012025-07-22
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
ETV/TDF+T101 No.1, ETV/TDF+T101 No.2, ETV or TDF - Hepatitis B Virus (HBV)
Phase 2UnknownTasly Tianjin Biopharmaceutical Co., Ltd.1002019-12-102021-02-08
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients
T101 Group, Placebo Group - Hepatitis B Virus (HBV)
Phase 1CompletedTasly Tianjin Biopharmaceutical Co., Ltd.362018-01-082019-12-04
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
Shear Wave Sonoelastography - Chronic Liver Disease, Non-Alcoholic Fatty Liver Disease
Not applicableCompletedMassachusetts General Hospital1802010-02-012017-06-14
Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection
Tenofovir disoproxil fumarate (TDF), Placebo - Hepatitis B Virus (HBV)
Phase 3CompletedGilead Sciences1062008-12-012016-09-01

Narrower conditions

Hepatitis B (10)  ·  Hepatitis C (4)  ·  Carcinoma, Hepatocellular (2)  ·  Fibrosis (2)  ·  Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Coinfection (1)  ·  Hepatitis B, Chronic (1)  ·  Hepatitis D (1)  ·  Liver Cirrhosis (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Social Stigma (1)  ·  Syphilis (1)

Broader conditions

Blood-Borne Infections (10)  ·  Communicable Diseases (10)  ·  DNA Virus Infections (10)  ·  Digestive System Diseases (10)  ·  Hepadnaviridae Infections (10)  ·  Hepatitis (10)  ·  Hepatitis, Viral, Human (10)  ·  Liver Diseases (10)  ·  Virus Diseases (10)  ·  Infections (8)  ·  Flaviviridae Infections (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  RNA Virus Infections (4)  ·  Adenocarcinoma (2)

Interventions

entecavir (2)  ·  Blood Specimen Collection (1)  ·  Sofosbuvir (1)  ·  Tenofovir (1)  ·  hepatitis B hyperimmune globulin (1)  ·  sofosbuvir-velpatasvir drug combination (1)  ·  velpatasvir (1)

Sponsors

Tasly Tianjin Biopharmaceutical Co., Ltd. (2)  ·  Duke University (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Gilead Sciences (1)  ·  Hospices Civils de Lyon (1)  ·  Massachusetts General Hospital (1)  ·  Nottingham University Hospitals NHS Trust (1)  ·  University Health Network, Toronto (1)  ·  West Virginia University (1)

Countries

China (3)  ·  United States (3)  ·  France (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

Anthony E Samir, MD (1)  ·  Benedetta Massetto, MD, PhD (1)  ·  Dana Bechtold, DO (1)  ·  Kathryn E Jack, PhD (1)  ·  Susanna Naggie, MD, MHS (1)  ·  Yingren Zhao, Professor (1)

Results publications

PMID 22544804

NIH funding

U01AI195193 (1)